10.06.2011 • News

Hong Kong Orders GSK To Recall Antibiotic Due to Plasticizer

Hong Kong has ordered GlaxoSmithKline(GSK) to recall an pediatric antibiotic manufactured in France over the presence of a plasticizer in the product, raising safety and quality concerns.       

The Department of Health said in a statement that diisodecyl phthalate (DIDP) was detected in GSK's Augmentin powder for syrup 156mg/5ml, a product for children.  A government laboratory test detected the presence of DIDP was two times higher than Europe's specific migration limit for food contact materials.

DIDP's safety for human consumption was not well established, but data from animal studies suggested long-term consumption of high levels of DIDP may affect the liver, the government said.      

The government said it had stepped up surveillance of pharmaceutical products containing flavoring agents after  Chinese media reports that Chinese importers had recalled bottled beverages from Taiwan that were suspected of being contaminated with a cancer-causing plastic additive.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.